Chargement en cours...
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
It is estimated that 10–20% of patients with pancreatic cancer present with resectable disease. Although surgery offers curative intent, the median survival following curative resection is less than 2 years. To improve clinical outcomes in this patient population, clinical studies have investigated...
Enregistré dans:
| Publié dans: | Hematol Oncol Clin North Am |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699862/ https://ncbi.nlm.nih.gov/pubmed/26226906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2015.04.011 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|